Salvage Chemotherapy and Recurrent Ovarian Cancer
Links shared publicly online about this topic
Bevacizumab Added to Chemotherapy Provides Meaningful Benefit in Recurrent Ovarian Cancer
onclive.com — “Women with recurrent platinum-sensitive ovarian cancer had a 50% improvement in PFS when bevacizumab was added to chemotherapy and continued as maintenance therapy.” View full resource at onclive.com
Most Recently Shared on July 27, 2011 at 7:45 pm By:
Bevacizumab Added to Chemotherapy Provides Meaningful Benefit in Recurrent Ovarian Cancer http://t.co/gLOIrDB
ChemoFx-assisted chemotherapy reduces treatment costs for recurrent ovarian cancer
news-medical.net — “A study demonstrating the cost savings realized through the use of the ChemoFx® Drug Response Marker for assisting selection of treatment in recurrent ovarian cancer was published recently in the American Journal of Obstetrics and Gynecology (AJOG).” View full resource at news-medical.net
Most Recently Shared on June 4, 2010 at 9:26 am By:
ChemoFx-assisted chemotherapy reduces treatment costs for recurrent ovarian cancer: A study demonstrating the cost... http://bit.ly/bn3YeK
Ovarian Cancer: Gynecologist Disputes Findings
medicalnewstoday.com — “An internationally-recognized gynecologic oncologist at St. Joseph's Hospital and Medical Center in Phoenix, Arizona is warning that the results from a long-awaited global study of ovarian cancer” View full resource at medicalnewstoday.com
Most Recently Shared on October 18, 2010 at 1:05 pm By:
Ovarian Cancer: Gynecologist Disputes Findings http://mnt.to/3Lm8 #clinicaltrials
Oncology Medical News about Ovarian Neoplasms Antineoplastic Combined Chemotherapy Protocols
mdlinx.com — “Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer” View full resource at mdlinx.com
Most Recently Shared on June 18, 2010 at 10:20 am By:
Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer... http://bit.ly/dBkn2n #oncology
Ovarian Cancer: eMedicine Oncology
emedicine.medscape.com — “Overview: Ovarian cancer is the most common cause of cancer death from gynecologic tumors in the United States. Early disease causes minimal, nonspecific, or no symptoms. Therefore, most cases are diagnosed in an advanced stage. Overall, prognosis ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 12, 2010 at 6:04 pm By:
Ovarian Cancer: Study finds cytoreductive surgery safe and effective in platinum-sensitive recurrent ovarian cancer. http://bit.ly/9ZmUBA
Medical News: ASCO: Targeted Agent Slows Recurrent Ovarian Cancer - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Women with recurrent platinum-sensitive ovarian cancer had a 50% improvement in progression-free survival when bevacizumab (Avastin) was added to chemotherapy, results of a multicenter rand” View full resource at medpagetoday.com
Most Recently Shared on June 8, 2011 at 10:08 pm By:
ASCO: Targeted Agent Slows Recurrent Ovarian Cancer (with video) http://bit.ly/m03Klj
Medical News: ASCO: Targeted Agent Slows Recurrent Ovarian Cancer - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Women with recurrent platinum-sensitive ovarian cancer had a 50% improvement in progression-free survival when bevacizumab (Avastin) was added to chemotherapy, results of a multicenter rand” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 7:24 pm By:
Medical News: ASCO: Targeted Agent Slows Recurrent Ovarian Cancer - http://t.co/DhFILLd from @medpagetoday #health #medicine
Medical News: SGO: Drug Combination Slows Recurrent Ovarian Cancer - in Meeting Coverage, SGO from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- Combination chemotherapy resulted in a longer, progression-free survival (PFS) than did sequential therapy in a randomized clinical trial of patients with recurrent, platinum-sensitiv” View full resource at medpagetoday.com
Most Recently Shared on March 15, 2010 at 2:41 pm By:
SGO: Drug Combination Slows Recurrent Ovarian Cancer (CME/CE) SAN FRANCISCO (MedPage Today) -- Combination chemothera.. http://bit.ly/bNbtkZ
Genentech Announces Data To Show Avastin-Based Regimen Halved The Risk Of Disease Getting Worse In Women With Recurrent Ovarian Cancer
medicalnewstoday.com — “Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from OCEANS, a Phase III study evaluating Avastin® (bevacizumab) in combination with chemotherapy (” View full resource at medicalnewstoday.com
Most Recently Shared on June 6, 2011 at 10:05 am By:
Genentech Announces Data To Show Avastin-Based Regimen Halved The Risk Of Disease Getting Worse In Women With Recurren... http://mnt.to/3WNk
Genentech Announces Data To Show Avastin-Based Regimen Halved The Risk Of Disease Getting Worse In Women With Recurrent Ovarian Cancer
medicalnewstoday.com — “Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from OCEANS, a Phase III study evaluating Avastin® (bevacizumab) in combination with chemotherapy (” View full resource at medicalnewstoday.com
Most Recently Shared on June 6, 2011 at 1:16 pm By:
Genentech Announces Data To Show Avastin-Based Regimen Halved The Risk Of Disease Getting Worse In Women With Re... http://bit.ly/m03fYD
Oncology Medical News about ovarian cancer
mdlinx.com — “A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer” View full resource at mdlinx.com
Most Recently Shared on January 13, 2010 at 10:11 am By:
Heme/Onc: A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer: Cancer Chemotherapy and Pharmacol http://url4.eu/17I5Z
Ob/Gyn Medical News about Ovarian Neoplasms Antineoplastic Combined Chemotherapy Protocols
mdlinx.com — “Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer” View full resource at mdlinx.com
Most Recently Shared on June 18, 2010 at 2:26 pm By:
Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer: Coc... http://bit.ly/dcVk1E #OBG
Oncology Article | Ovarian Neoplasms
mdlinx.com — “Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease” View full resource at mdlinx.com
Most Recently Shared on April 12, 2011 at 10:31 am By:
Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and r... http://bit.ly/hH6IxF #oncology
Medical News: No Benefit for Early Tx of Ovarian Cancer Relapse - in Oncology/Hematology, Ovarian Cancer from MedPage Today
medpagetoday.com — “Women who get early chemotherapy for a recurrence of ovarian cancer won't live longer, researchers say.” View full resource at medpagetoday.com
Most Recently Shared on October 1, 2010 at 1:50 pm By:
No Benefit for Early Tx of Ovarian Cancer Relapse (CME/CE) http://bit.ly/cqrGfz
New treatment shows promise against recurrent gynecologic cancers
physorg.com — “(BRONX, NY) - Recurrent and metastatic endometrial and ovarian cancers can be notoriously difficult to treat: They have spread to other organs and typically have developed resistance to chemotherapy; and patients already heavily treated with chemotherapy may not be able to endure more chemo. Now, physicians ...” View full resource at physorg.com
Most Recently Shared on April 21, 2009 at 11:55 pm By:
New treatment shows promise against recurrent gynecologic cancers http://tinyurl.com/cgnpe9
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Editor
Editors of Oncology & Biotech News/Oncology Net Guide/OncNurse/Contemporary Oncology, on cancer news from pharma, trials, technology, & more.
-
News-Medical.Net
Medical News from Around the World
-
MNT Clinical Trials
The latest clinical trials news published daily. Articles from research centers, universities and prestigious journals.
Advertisement

